Key result
Perindopril withdrawal in Lyon hypertensive rats resulted in durable renoprotection and a smaller blood pressure increase after salt load (+30 mm Hg) compared to double or triple therapy (+50 mm Hg).
Why the study?
Does perindopril provide durable renoprotection after treatment withdrawal compared to other antihypertensives in Lyon hypertensive rats?
Does perindopril provide durable renoprotection after treatment withdrawal compared to other antihypertensives in Lyon hypertensive rats?
Angiotensin-converting enzyme inhibition with perindopril provides durable renoprotection after treatment withdrawal in hypertensive rats, independent of blood pressure lowering.
Answers are grounded in this paper and cite their sources.
May suggest durable renoprotection after perindopril withdrawal in hypertensive rats; leaves open human translation and requires clinical validation.
To determine whether the persistent antihypertensive effect observed after withdrawal of angiotensin-converting enzyme inhibition was specific and whether it was associated with durable improvement of renal function. Lyon hypertensive (LH) rats were treated from 3 and 12 weeks of age with perindopril at the dose of 0.4 (P0.4) or 1.5 (P1.5) mg·kg(-1)·d(-1), with double (hydralazine 75 mg·kg(-1)·d(-1) and hydrochlorothiazide 15 mg·kg(-1)·d(-1)), or triple antihypertensive therapy (reserpine 0.75 mg·kg(-1)·d(-1) was added). Blood pressure (BP) was recorded by telemetry, and renal functions were evaluated in freely moving rats. Despite similar BP reduction after perindopril withdrawal in P0.4 and P1.5 groups, greater decrease in proteinuria was observed in P1.5 group. Double or triple therapy prevented the hypertension of LH rats, but without any persistent antihypertensive or antiproteinuric effect after its withdrawal. Salt load elicited an increase in BP that was similar in untreated LH and both perindopril-pretreated groups (+30 mm Hg), but more pronounced in double therapy–pretreated or triple therapy–pretreated groups (+50 mm Hg). The pressure–natriuresis curve shifted to lower BP levels in P0.4 and P1.5 groups, whereas it was blunted in double and triple therapy groups. Angiotensin-converting enzyme inhibition has a durable renoprotection after treatment withdrawal that is independent of BP lowing.
No takes yet. Share an insight, caveat, or question.
Naelten et al. (2010) studied Hypertension. Perindopril vs. Double or triple antihypertensive therapy, or untreated was evaluated on Blood pressure increase after salt load following treatment withdrawal. Perindopril withdrawal in Lyon hypertensive rats resulted in durable renoprotection and a smaller blood pressure increase after salt load (+30 mm Hg) compared to double or triple therapy (+50 mm Hg).
Synapse has enriched 10 related papers. Consider them for comparative context: